Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

A Prostate Cancer Composite Score to Identify High Burden Neighborhoods.

McIntire RK, Keith SW, Boamah M, Leader AE, Glanz K, Klassen AC, Zeigler-Johnson CM.

Prev Med. 2018 Jul;112:47-53. doi: 10.1016/j.ypmed.2018.04.003. Epub 2018 Apr 4.

2.

Inflammation polymorphisms and prostate cancer risk in Jamaican men: Role of obesity/body size.

Dubey B, Jackson MD, Zeigler-Johnson C, Devarajan K, Flores-Obando RE, McFarlane-Anderson N, Tulloch-Reid MK, Aiken W, Kimbro K, Jones DZ, Kidd LR, Ragin C.

Gene. 2017 Dec 15;636:96-102. doi: 10.1016/j.gene.2017.09.016. Epub 2017 Sep 10.

PMID:
28903065
3.

A Neighborhood-Wide Association Study (NWAS): Example of prostate cancer aggressiveness.

Lynch SM, Mitra N, Ross M, Newcomb C, Dailey K, Jackson T, Zeigler-Johnson CM, Riethman H, Branas CC, Rebbeck TR.

PLoS One. 2017 Mar 27;12(3):e0174548. doi: 10.1371/journal.pone.0174548. eCollection 2017.

4.

The Relationship between Obesity, Prostate Tumor Infiltrating Lymphocytes and Macrophages, and Biochemical Failure.

Zeigler-Johnson C, Morales KH, Lal P, Feldman M.

PLoS One. 2016 Aug 3;11(8):e0159109. doi: 10.1371/journal.pone.0159109. eCollection 2016.

5.

The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer.

Yamoah K, Zeigler-Johnson CM, Jeffers A, Malkowicz B, Spangler E, Park JY, Whittemore A, Rebbeck TR.

BMC Cancer. 2016 Jul 29;16:557. doi: 10.1186/s12885-016-2572-y.

6.

Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.

Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG.

J Cancer Educ. 2018 Feb;33(1):180-185. doi: 10.1007/s13187-016-1073-7.

PMID:
27418065
7.

Individual- and neighborhood-level education influences the effect of obesity on prostate cancer treatment failure after prostatectomy.

Zeigler-Johnson C, Morales KH, Glanz K, Spangler E, Mitchell J, Rebbeck TR.

Cancer Causes Control. 2015 Sep;26(9):1329-37. doi: 10.1007/s10552-015-0628-y. Epub 2015 Jul 14.

8.

Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.

Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, Ostrander EA, Stanford JL, Batra J, Clements JA, Chambers SK, Weischer M, Nordestgaard BG, Ingles SA, Sorensen KD, Orntoft TF, Park JY, Cybulski C, Maier C, Doerk T, Dickinson JL, Cannon-Albright L, Brenner H, Rebbeck TR, Zeigler-Johnson C, Habuchi T, Thibodeau SN, Cooney KA, Chappuis PO, Hutter P, Kaneva RP, Foulkes WD, Zeegers MP, Lu YJ, Zhang HW, Stephenson R, Cox A, Southey MC, Spurdle AB, FitzGerald L, Leongamornlert D, Saunders E, Tymrakiewicz M, Guy M, Dadaev T, Little SJ, Govindasami K, Sawyer E, Wilkinson R, Herkommer K, Hopper JL, Lophatonanon A, Rinckleb AE, Kote-Jarai Z, Eeles RA, Easton DF; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators; PRACTICAL Consortium.

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1121-9. doi: 10.1158/1055-9965.EPI-14-0317. Epub 2015 Apr 2.

9.

African-american race is a predictor of seminal vesicle invasion after radical prostatectomy.

Yamoah K, Walker A, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Dicker AP, Rebbeck TR, Lal P.

Clin Genitourin Cancer. 2015 Apr;13(2):e65-72. doi: 10.1016/j.clgc.2014.08.012. Epub 2014 Oct 25.

10.

African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.

Yamoah K, Deville C, Vapiwala N, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Kattan M, Dicker AP, Rebbeck TR.

Urol Oncol. 2015 Feb;33(2):70.e15-22. doi: 10.1016/j.urolonc.2014.07.005. Epub 2014 Oct 7.

11.

Gender- and ethnic-specific associations with obesity: individual and neighborhood-level factors.

Zeigler-Johnson C, Weber A, Glanz K, Spangler E, Rebbeck TR.

J Natl Med Assoc. 2013 Summer;105(2):173-82.

PMID:
24079218
12.

Relationship of early-onset baldness to prostate cancer in African-American men.

Zeigler-Johnson C, Morales KH, Spangler E, Chang BL, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):589-96. doi: 10.1158/1055-9965.EPI-12-0944. Epub 2013 Mar 26.

13.

Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent.

Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, Isaacs W, Jalloh M, John EM, Kibel AS, Kidd LR, Layne P, Leach RJ, Neslund-Dudas C, Okobia MN, Ostrander EA, Park JY, Patrick AL, Phelan CM, Ragin C, Roberts RA, Rybicki BA, Stanford JL, Strom S, Thompson IM, Witte J, Xu J, Yeboah E, Hsing AW, Zeigler-Johnson CM.

Prostate Cancer. 2013;2013:560857. doi: 10.1155/2013/560857. Epub 2013 Feb 13.

14.

What stresses men? Predictors of perceived stress in a population-based multi-ethnic cross sectional cohort.

Rebbeck TR, Weber AL, Spangler E, Zeigler-Johnson CM.

BMC Public Health. 2013 Feb 6;13:113. doi: 10.1186/1471-2458-13-113.

15.

Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men.

Fernandez P, Zeigler-Johnson CM, Spangler E, van der Merwe A, Jalloh M, Gueye SM, Rebbeck TR.

Prostate Cancer. 2012;2012:798634. doi: 10.1155/2012/798634. Epub 2012 Oct 2.

16.

Prostate cancer severity associations with neighborhood deprivation.

Zeigler-Johnson CM, Tierney A, Rebbeck TR, Rundle A.

Prostate Cancer. 2011;2011:846263. doi: 10.1155/2011/846263. Epub 2011 Oct 9.

17.

Relationship of obesity, androgen receptor genotypes and biochemical failure after radical prostatectomy.

Zeigler-Johnson C, Weber A, Spangler E, Panossian S, Rebbeck TR, Malkowicz SB.

Prostate. 2012 Jun 15;72(9):984-90. doi: 10.1002/pros.21503. Epub 2011 Oct 24.

PMID:
22025404
18.

Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent.

Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, Patrick AL, Rebbeck TR, Romana M, Stanford JL, Ukoli F, Vancleave TT, Zeigler-Johnson CM, Mutetwa B, Ragin C.

Carcinogenesis. 2011 Sep;32(9):1361-5. doi: 10.1093/carcin/bgr119. Epub 2011 Jun 24.

19.

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.

Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, Cooney KA, Xu J, Kibel AS, Hu JJ, John EM, Gueye SM, Watya S, Signorello LB, Hayes RB, Wang Z, Yeboah E, Tettey Y, Cai Q, Kolb S, Ostrander EA, Zeigler-Johnson C, Yamamura Y, Neslund-Dudas C, Haslag-Minoff J, Wu W, Thomas V, Allen GO, Murphy A, Chang BL, Zheng SL, Leske MC, Wu SY, Ray AM, Hennis AJ, Thun MJ, Carpten J, Casey G, Carter EN, Duarte ER, Xia LY, Sheng X, Wan P, Pooler LC, Cheng I, Monroe KR, Schumacher F, Le Marchand L, Kolonel LN, Chanock SJ, Van Den Berg D, Stram DO, Henderson BE.

Nat Genet. 2011 Jun;43(6):570-3. doi: 10.1038/ng.839. Epub 2011 May 22.

20.

Decision tree-based modeling of androgen pathway genes and prostate cancer risk.

Barnholtz-Sloan JS, Guan X, Zeigler-Johnson C, Meropol NJ, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1146-55. doi: 10.1158/1055-9965.EPI-10-0996. Epub 2011 Apr 14.

21.

Validation of genome-wide prostate cancer associations in men of African descent.

Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom S, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, Giri VN, Rybicki B, Neslund-Dudas C, Kibel AS, Thompson IM, Leach RJ, Ostrander EA, Stanford JL, Witte J, Casey G, Eeles R, Hsing AW, Chanock S, Hu JJ, John EM, Park J, Stefflova K, Zeigler-Johnson C, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):23-32. doi: 10.1158/1055-9965.EPI-10-0698. Epub 2010 Nov 11.

22.

Context-dependent effects of genome-wide association study genotypes and macroenvironment on time to biochemical (prostate specific antigen) failure after prostatectomy.

Rebbeck TR, Weber AL, Walker AH, Stefflova K, Tran TV, Spangler E, Chang BL, Zeigler-Johnson CM.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2115-23. doi: 10.1158/1055-9965.EPI-10-0173.

23.

Dietary intake of Senegalese adults.

Anderson CA, Bellamy S, Figures M, Zeigler-Johnson C, Jalloh M, Spangler E, Coomes M, Gueye S, Rebbeck TR.

Nutr J. 2010 Feb 18;9:7. doi: 10.1186/1475-2891-9-7.

24.

Evaluation of group genetic ancestry of populations from Philadelphia and Dakar in the context of sex-biased admixture in the Americas.

Stefflova K, Dulik MC, Pai AA, Walker AH, Zeigler-Johnson CM, Gueye SM, Schurr TG, Rebbeck TR.

PLoS One. 2009 Nov 25;4(11):e7842. doi: 10.1371/journal.pone.0007842.

25.

Common 8q24 sequence variations are associated with Asian Indian advanced prostate cancer risk.

Tan YC, Zeigler-Johnson C, Mittal RD, Mandhani A, Mital B, Rebbeck TR, Rennert H.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2431-5. doi: 10.1158/1055-9965.EPI-07-2823.

26.

Evaluation of prostate cancer characteristics in four populations worldwide.

Zeigler-Johnson CM, Rennert H, Mittal RD, Jalloh M, Sachdeva R, Malkowicz SB, Mandhani A, Mittal B, Gueye SM, Rebbeck TR.

Can J Urol. 2008 Jun;15(3):4056-64.

27.

Joint effects of inflammation and androgen metabolism on prostate cancer severity.

Rebbeck TR, Rennert H, Walker AH, Panossian S, Tran T, Walker K, Spangler E, Patacsil-Coomes M, Sachdeva R, Wein AJ, Malkowicz SB, Zeigler-Johnson C.

Int J Cancer. 2008 Sep 15;123(6):1385-9. doi: 10.1002/ijc.23687.

28.

Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer.

Rennert H, Zeigler-Johnson C, Mittal RD, Tan YC, Sadowl CM, Edwards J, Finley MJ, Mandhani A, Mital B, Rebbeck TR.

Urology. 2008 Aug;72(2):456-60. doi: 10.1016/j.urology.2007.11.139. Epub 2008 Apr 24.

29.

A study of PSA values in an unselected sample of Senegalese men.

Jalloh M, Zeigler-Johnson C, Sylla-Niang M, Niang L, Labou I, Konte KA, Rebbeck TR, Gueye S.

Can J Urol. 2008 Feb;15(1):3883-5.

30.

Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes.

Zeigler-Johnson CM, Spangler E, Jalloh M, Gueye SM, Rennert H, Rebbeck TR.

Can J Urol. 2008 Feb;15(1):3872-82. Review.

31.

Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men.

Spangler E, Zeigler-Johnson CM, Coomes M, Malkowicz SB, Wein A, Rebbeck TR.

J Urol. 2007 Nov;178(5):1939-44; discussion 1945. Epub 2007 Sep 17.

PMID:
17868722
32.

Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.

Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):949-57.

33.

CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer.

Zeigler-Johnson C, Friebel T, Walker AH, Wang Y, Spangler E, Panossian S, Patacsil M, Aplenc R, Wein AJ, Malkowicz SB, Rebbeck TR.

Cancer Res. 2004 Nov 15;64(22):8461-7.

34.

Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors.

Spangler E, Zeigler-Johnson CM, Malkowicz SB, Wein AJ, Rebbeck TR.

Int J Cancer. 2005 Jan 20;113(3):471-4.

35.

Population differences in the frequency of the agouti signaling protein g.8818a>G polymorphism.

Zeigler-Johnson C, Panossian S, Gueye SM, Jalloh M, Ofori-Adjei D, Kanetsky PA.

Pigment Cell Res. 2004 Apr;17(2):185-7.

PMID:
15016309
36.

Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men.

Gueye SM, Zeigler-Johnson CM, Friebel T, Spangler E, Jalloh M, MacBride S, Malkowicz SB, Rebbeck TR.

Urology. 2003 May;61(5):987-92.

PMID:
12736021
37.

CYP3A4: a potential prostate cancer risk factor for high-risk groups.

Zeigler-Johnson C.

Clin J Oncol Nurs. 2001 Jul-Aug;5(4):153-4.

PMID:
12690615
38.

Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4.

Zeigler-Johnson CM, Walker AH, Mancke B, Spangler E, Jalloh M, McBride S, Deitz A, Malkowicz SB, Ofori-Adjei D, Gueye SM, Rebbeck TR.

Hum Hered. 2002;54(1):13-21.

PMID:
12446983
39.

Association of HPC2/ELAC2 genotypes and prostate cancer.

Rebbeck TR, Walker AH, Zeigler-Johnson C, Weisburg S, Martin AM, Nathanson KL, Wein AJ, Malkowicz SB.

Am J Hum Genet. 2000 Oct;67(4):1014-9. Epub 2000 Sep 12.

40.

Subclinical atherosclerosis in relation to hysterectomy status in black women.

Zeigler-Johnson CM, Holmes JL, Lassila HC, Sutton-Tyrrell K, Kuller LH.

Stroke. 1998 Apr;29(4):759-64.

41.

High homocysteine levels are independently related to isolated systolic hypertension in older adults.

Sutton-Tyrrell K, Bostom A, Selhub J, Zeigler-Johnson C.

Circulation. 1997 Sep 16;96(6):1745-9.

Supplemental Content

Loading ...
Support Center